Acute pancreatitis without abdominal pain induced by administration of nivolumab and ipilimumab-Reference-Cited by-同舟云学术

Acute pancreatitis without abdominal pain induced by administration of nivolumab and ipilimumab

Published:2021-04-03 Issue:2 Volume:5 Page:425-430
ISSN:2472-5625
Container-title:Modern Rheumatology Case Reports
language:en
Short-container-title:Modern Rheumatology Case Reports

Author:

Yamamoto Koichiro¹^ORCID,Oka Kosuke¹,Son Reina¹,Honda Hiroyuki¹,Sakae Hiroyuki¹²,Hasegawa Kou¹,Horiguchi Shigeru¹²,Kato Hironari²,Yamasaki Osamu³,Otsuka Fumio¹^ORCID

Affiliation:

1. Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

2. Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

3. Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/24725625.2021.1899444

Reference21 articles.

3. Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab

4. Risk of Immune-Related Pancreatitis in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors: Systematic Assessment with Meta-Analysis

5. Anti–PD-1 Drug (Nivolumab) May Induce Acute and Life-Threatening Pancreatitis in Lung Cancer Patient

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS);Frontiers in Pharmacology;2023-11-17

2. Rituximab in steroid-refractory immune-related pancreatitis: a case report;Frontiers in Oncology;2023-07-31

3. Immune Checkpoint Inhibitor-induced Pancreatitis with Pancreatic Enlargement Mimicking Autoimmune Pancreatitis: A Case Report and Review of the Literature;Internal Medicine;2023

4. Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis);Current Opinion in Gastroenterology;2022-07-15

5. Pembrolizumab-Induced Myocarditis and Pancreatitis in a Patient With Colon Cancer: A Case Report;Cureus;2022-06-17